. 2014 Apr 23;5:78. doi: 10.3389/fphar.2014.00078

Table 1.

Effect of HLE-FP on body weight in the sub-chronic oral toxicity study.

Group	1st day	15th day	30th day	30th day	45th day	60th day	60th day
	wt. (g)	wt. (g)	wt. (g)	%Δwt.	wt. (g)	wt. (g)	%Δwt.
I	120.40 ± 24.25	136.80 ± 17.24	159.10 ± 19.80	34.32 ± 18.47^a	173.60 ± 18.00	187.40 ± 20.74	55.65 ± 25.06^a
II	108.80 ± 7.45	134.70 ± 08.09	153.80 ± 21.04	41.67 ± 21.04	164.10 ± 18.19	191.20 ± 16.71	71.92 ± 09.57^a
III	121.80 ± 17.10	144.00 ± 19.42	161.30 ± 18.71	28.02 ± 32.16^a	165.90 ± 16.08	191.80 ± 23.51	69.02 ± 29.44^a
IV	86.33 ± 23.40	129.30 ± 16.31	151.10 ± 12.40	85.62 ± 44.65	163.30 ± 11.05	175.20 ± 18.83	102.94 ± 15.50

Represents a significant decrease at p < 0.05 compared to control values (Group IV).

I, 500 mg/kg/day HLE-FP; II, 100 mg/kg/day HLE-FP; III, 20 mg/kg/day HLE-FP; IV, 10 ml/kg normal saline.